Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 12847-12848 [2017-04363]

Download as PDF Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,1 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: March 1, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–04343 Filed 3–6–17; 8:45 am] BILLING CODE 7020–02–P JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Advisory; Committee on Rules of Criminal Procedure Advisory Committee on Rules of Criminal Procedure, Judicial Conference of the United States. ACTION: Notice of open meeting. AGENCY: The Advisory Committee on Rules of Criminal Procedure will hold a meeting on April 28, 2017. The meeting will be open to public observation but not participation. An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: http://www.uscourts.gov/rulespolicies/records-and-archives-rulescommittees/agenda-books. DATES: April 28, 2017 from 8:30 a.m.– 5:30 p.m. ADDRESSES: Thurgood Marshall Federal Judiciary Building, Mecham Conference Center, Administrative Office of the United States Courts, One Columbus Circle NE., Washington, DC 20544. FOR FURTHER INFORMATION CONTACT: Rebecca A. Womeldorf, Rules Committee Secretary, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: 1 All contract personnel will sign appropriate nondisclosure agreements. VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 Dated: February 27, 2017. Rebecca A. Womeldorf, Rules Committee Secretary. [FR Doc. 2017–04322 Filed 3–6–17; 8:45 am] BILLING CODE 2210–55–P JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Advisory; Committee on Rules of Civil Procedure Advisory Committee on Rules of Civil Procedure, Judicial Conference of the United States. ACTION: Notice of open meeting. AGENCY: The Advisory Committee on Rules of Civil Procedure will hold a meeting on April 25–26, 2017. The meeting will be open to public observation but not participation. An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: http://www.uscourts.gov/ rules-policies/records-and-archivesrules-committees/agenda-books. DATES: April 25–9:00 a.m. to 5:00 p.m. April 26–9:00 a.m. to 12:00 p.m. ADDRESSES: Hotel Ella, 1900 Rio Grande, Austin, Texas 78705. FOR FURTHER INFORMATION CONTACT: Rebecca A. Womeldorf, Rules Committee Secretary, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. SUMMARY: Dated: February 28, 2017. Rebecca A. Womeldorf, Rules Committee Secretary. BILLING CODE 2210–55–P Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Pistoia Alliance, Inc. Notice is hereby given that, on February 3, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages Fmt 4703 Sfmt 4703 Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–04362 Filed 3–6–17; 8:45 am] BILLING CODE 4410–11–P Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium DEPARTMENT OF JUSTICE Frm 00066 under specified circumstances. Specifically, Odysseus Data Services Inc., Cambridge, MA; Mike Furness (individual member), Ely, Cambridgeshire, United Kingdom; and Copyright Clearance Center, Danvers, MA, have been added as parties to this venture. Also, Sanofi, Frankfurt, Germany; BioReference Laboratories, Elmwood Park, NJ; BioVariance GmbH, Munich, Germany; and UCB Pharma SA, Brussels, Belgium, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364). The last notification was filed with the Department on November 14, 2016. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on December 13, 2016 (81 FR 89992). DEPARTMENT OF JUSTICE [FR Doc. 2017–04320 Filed 3–6–17; 8:45 am] PO 00000 12847 Notice is hereby given that, on February 3, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Biologics Modular, Brownsburg, IN; DynPort Vaccine Company, LLC, a CSRA Company, E:\FR\FM\07MRN1.SGM 07MRN1 12848 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices Frederick, MD; Biological Mimetics, Inc., Frederick, MD; Janssen Research & Development, LLC, Raritan, NJ; SAB Biotherapeutics, Inc., Sioux Falls, SD; Meridian Medical Technologies, Inc., Columbia, MD; Flow Pharma, Inc., East Palo Alto, CA; Bavarian Nordic, Inc., Washington, DC; and Parsons Government Services, Inc., Pasadena, CA, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on November 16, 2016. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on December 13, 2016 (81 FR 89978). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–04363 Filed 3–6–17; 8:45 am] study to evaluate the emissions capture and control effectiveness of each of its air pollution control systems; (2) conduct performance stack tests; (3) conduct monitoring of visible emissions; (4) install and operate various monitors to alert operators of malfunctions with the air pollution control systems; (5) perform air dispersion modeling; (6) continue implementing and complying with RCRA requirements for the storage, handling, and transport, and disposal of its hazardous waste; and (7) pay a civil penalty based on an inability-to-pay analysis. The Defendant will pay civil penalties of $25,000 to the United States. The publication of this notice opens a period for public comment on the consent decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States of America v. Maynard Steel Casting Company, D.J. Ref. No. 90–5–2–1–10613. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by U.S. mail: To submit comments: Send them to: By email ....... BILLING CODE 4410–11–P pubcomment-ees.enrd@ usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. DEPARTMENT OF JUSTICE By U.S. mail sradovich on DSK3GMQ082PROD with NOTICES Notice of Lodging of Proposed Consent Decree Under The Clean Air Act and Resource Conservation and Recovery Act On March 1, 2017, the Department of Justice lodged a proposed consent decree with the United States District Court for the Eastern District of Wisconsin, in the lawsuit entitled United States of America v. Maynard Steel Casting Company, Civil Action No. 2:17–cv–00292. The United States filed this lawsuit against the Maynard Steel Casting Company (‘‘Defendant’’) under the Clean Air Act and the Resource Conversation and Recovery Act. The complaint seeks injunctive relief and civil penalties for violations of the Clean Air Act (‘‘CAA’’), 42 U.S.C. 7401 et seq., the Resource Conservation and Recovery Act (‘‘RCRA’’), 42 U.S.C. 6901 et seq., and their implementing regulations. The consent decree resolves the allegations in the complaint and requires the Defendant to: (1) Perform a VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 During the public comment period, the consent decree may be examined and downloaded at this Justice Department Web site: https:// www.justice.gov/enrd/consent-decrees. We will provide a paper copy of the consent decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ— ENRD, P.O. Box 7611, Washington, DC 20044–7611. For a paper copy of the entire Consent Decree with appendices (142 pages at 25 cents per page reproduction cost), please enclose a check or money order for $35.50 made payable to the United States Treasury. For a paper copy PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 without the appendices and signature pages, the cost is $13.25. Randall M. Stone, Acting Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2017–04364 Filed 3–6–17; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF LABOR Office of the Secretary Agency Information Collection Activities; Submission for OMB Review; Comment Request; Application for Approval of a Representative’s Fee in Black Lung Claim Proceedings Conducted by the U.S. Department of Labor ACTION: Notice. The Department of Labor (DOL) is submitting the Office of Workers’ Compensation Programs (OWCP) sponsored information collection request (ICR) titled, ‘‘Application for Approval of a Representative’s Fee in Black Lung Claim Proceedings Conducted by the U.S. Department of Labor,’’ to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that agency receives on or before April 6, 2017. ADDRESSES: A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained free of charge from the RegInfo.gov Web site at http:// www.reginfo.gov/public/do/ PRAViewICR?ref_nbr=201611-1240-001 (this link will only become active on the day following publication of this notice) or by contacting Michel Smyth by telephone at 202–693–4129, TTY 202– 693–8064, (these are not toll-free numbers) or by email at DOL_PRA_ PUBLIC@dol.gov. Submit comments about this request by mail or courier to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL– OWCP, Office of Management and Budget, Room 10235, 725 17th Street NW., Washington, DC 20503; by Fax: 202–395–5806 (this is not a toll-free number); or by email: OIRA_ submission@omb.eop.gov. Commenters SUMMARY: E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)]
[Notices]
[Pages 12847-12848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04363]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on February 3, 2017, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense 
Consortium (``MCDC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Biologics Modular, Brownsburg, IN; DynPort Vaccine 
Company, LLC, a CSRA Company,

[[Page 12848]]

Frederick, MD; Biological Mimetics, Inc., Frederick, MD; Janssen 
Research & Development, LLC, Raritan, NJ; SAB Biotherapeutics, Inc., 
Sioux Falls, SD; Meridian Medical Technologies, Inc., Columbia, MD; 
Flow Pharma, Inc., East Palo Alto, CA; Bavarian Nordic, Inc., 
Washington, DC; and Parsons Government Services, Inc., Pasadena, CA, 
have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on November 16, 
2016. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on December 13, 2016 (81 FR 89978).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-04363 Filed 3-6-17; 8:45 am]
 BILLING CODE 4410-11-P